Chongqing Huapont Shengchem Pharmaceutical Co., Ltd.
Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. was established in 2007; it is the subsidiary company of Chongqing Huapont Pharmaceutical Co., Ltd. Since the request of the production capacity and quality management, the production and quality management based on GMP of US/ICH is implemented.
The APIs manufactured in Huapont Shengchem are supplied not only to headquarter (Chongqing Huapont Pharmaceutical Co., Ltd.) and also to foreign companies. After several years of hardly efforts, the company has become an exporting base of APIs where is inspected and approved by US-FDA, and other countries authorities, like Medsaf from New Zealand, COFEPRIS from Mexico as well as CFDA of China.
At present, ours APIs have exported to all over the world covering about 30 countries. A stable and close relationship have built with more than 70 clients which include the world’s leading pharmaceutical companies, such as ACTIVAS, JOHNSON&JOHNSON, WYETH, TEVA, SANDOZ, SANOFI-AVENTIS and APOTEX. The objective of supplying high quality of APIs is greeting for all clients.